NSEBSECOMMODITYNASDAQNYSEFOREXINDICESAMEXUSA .

Famous Munafa Ebook, free scanners! Intraday scanner, FNO scanner, High profit BTST stocks!

Sonoma Pharmaceuticals (SNOA) Technical (Analysis) Reports Sonoma Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Sonoma Pharmaceuticals (SNOA)

Technical Analysis Report for USA stock SNOA Sonoma Pharmaceuticals. Dated: 10 Apr 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange

If you are looking for Tomorrow's Movement Predictions for USA stock SNOA Sonoma Pharmaceuticals then click here. or read Experts views on Sonoma Pharmaceuticals or Forecast & share price targets of Sonoma Pharmaceuticals

Sonoma Pharmaceuticals Opened at 2.38 and Closed at: 2.28, which is -5.7% of previous session's close. It moved within a range of 2.25 and 2.38
The session was a Bearish session with an average volume of 31200, which is -170.51% of previous session's volumes.

• The stock has fallen, and its mid term trend is also negative and in a downtrend.

Support for tomorrow is 2.2 and resistance for tomorrow is 2.33
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 2.23, 2.17 resistance for tomorrow's hourly charts is 2.36, 2.43

10 Day SMA for Sonoma Pharmaceuticals (SNOA) is 2.26 and stock is trading above these levels. This is a good sign for its short term trend

20 Day SMA for Sonoma Pharmaceuticals (SNOA) is 2.33 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Sonoma Pharmaceuticals (SNOA) is 2.66 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 3.07 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Sonoma Pharmaceuticals is 3.48 and stock is trading below these levels. This is not a good sign for its long term trend

20 DMA of Sonoma Pharmaceuticals is at 2.33 and 200 DMA is at 3.48, while 50 DMA and 100 DMA are at 2.66 and 3.07 respectively

Sonoma Pharmaceuticals (SNOA) moving average of 20 SMA is at 2.33 and 20 EMA is at 2.35

Sonoma Pharmaceuticals (SNOA) moving average of 50 SMA is at 2.66 and 50 EMA is at 2.65

Sonoma Pharmaceuticals (SNOA) moving average of 100 SMA is at 3.07 and 100 EMA is at 2.96

Sonoma Pharmaceuticals (SNOA) moving average of 200 SMA is at 3.48 and 200 EMA is at 3.12

Qiagen N has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Qiagen N, about 6.38% more returns!

Davita Inc has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Davita Inc, about 4.97% more returns!

Supernus Pharmaceuticals has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Supernus Pharmaceuticals, about 7.38% more returns!

Phibro Animal has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Phibro Animal, about 25.08% more returns!

Ovid Therapeutics has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Ovid Therapeutics, about 44.25% more returns!

Sonoma Pharmaceuticals has performed better than Outlook Therapeutics in short term. Holding Sonoma Pharmaceuticals could be a better choice for now!

Neurocrine Biosciences has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Neurocrine Biosciences, about 7.81% more returns!

Marker Therapeutics has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Marker Therapeutics, about 36.57% more returns!

Mesoblast has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Mesoblast, about 6.48% more returns!

Sonoma Pharmaceuticals has performed better than Galectin Therapeutics in short term. Holding Sonoma Pharmaceuticals could be a better choice for now!

Sonoma Pharmaceuticals has performed better than Equillium Inc in short term. Holding Sonoma Pharmaceuticals could be a better choice for now!

Sonoma Pharmaceuticals has performed better than Cytomx Therapeutics in short term. Holding Sonoma Pharmaceuticals could be a better choice for now!

Cerus Corporation has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Cerus Corporation, about 18.12% more returns!

Sonoma Pharmaceuticals has performed better than Atara Biotherapeutics in short term. Holding Sonoma Pharmaceuticals could be a better choice for now!

Allogene Therapeutics has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Allogene Therapeutics, about 17.06% more returns!

Sonoma Pharmaceuticals has performed better than Adial Pharmaceuticals in short term. Holding Sonoma Pharmaceuticals could be a better choice for now!

Sonoma Pharmaceuticals Technical analysis of indicators

Price action analysis of Sonoma Pharmaceuticals (SNOA) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.

ADX buy sell signal for Sonoma Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is losing momentum.

MACD generated a BUY signal for Sonoma Pharmaceuticals in short term but the buy signal is initial and weak.

Sonoma Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Sonoma Pharmaceuticals in short term but SELL signal is weak.

RSI is generating a SELL signal in short term and selling is picking up momentum.

MRSI is in negative zone. This is the SELL zone

Although the stock is in the SELL zone, but selling might be slowing down

Stock of Sonoma Pharmaceuticals is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 2.28 and Sonoma Pharmaceuticals SNOA stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.

People seem to be coming out and selling the Sonoma Pharmaceuticals SNOA stock. Volume based technical analysis of Sonoma Pharmaceuticals SNOA stock is negative.

Sonoma Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for USA stock SNOA Sonoma Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And SNOA Experts View which covers a lot of information including buying and selling signals

SNOA future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Sonoma Pharmaceuticals or View Candle Stick Charts here

Share on: WhatsApp Facebook Tweet